#1 Clinical Trials Search in Europe

Carbamazepine

Carbamazepine, a widely used medication, is being studied in clinical trials for its potential benefits in treating various medical conditions beyond its traditional use as an anticonvulsant. This article explores recent clinical trials investigating carbamazepine’s efficacy and safety in conditions such as liver disease, bipolar disorder, trigeminal neuralgia, neuropathic pain, and even asthma. By examining these trials, we can gain insights into the drug’s versatility and potential new applications in medical treatment.

Table of Contents

What is Carbamazepine?

Carbamazepine is a medication that has been used for many years to treat various neurological and psychiatric conditions. It’s known by several brand names, including Tegretol, Equetro, and Auration[1]. Carbamazepine comes in different formulations, including immediate-release tablets and controlled-release (CR) tablets, which release the medication slowly over time[1].

Medical Uses

Carbamazepine is used to treat several conditions:

  • Epilepsy: It’s an antiepileptic drug used to control seizures[1].
  • Trigeminal Neuralgia: This is a condition causing severe facial pain. Carbamazepine is often the first-line treatment for this condition[2].
  • Bipolar Disorder: It’s used as a mood stabilizer in bipolar disorder, particularly for manic or mixed episodes[3].
  • Neuropathic Pain: It can help relieve nerve pain in various conditions[4].

How Carbamazepine Works

Carbamazepine works by stabilizing nerve membranes and reducing excessive nerve signals in the brain. This action helps prevent seizures, reduce pain signals, and stabilize mood. It’s classified as an anticonvulsant and mood-stabilizing drug[1].

Dosage and Administration

The dosage of carbamazepine varies depending on the condition being treated and the individual patient’s response. It’s typically started at a low dose and gradually increased to find the most effective dose with the least side effects. For example:

  • For bipolar disorder in children and adolescents, doses may range from 200-1200 mg per day, given in divided doses[3].
  • For trigeminal neuralgia, the dose is often titrated (gradually adjusted) according to the patient’s needs[2].
  • Controlled-release formulations are usually taken twice daily[1].

It’s important to take carbamazepine exactly as prescribed by your doctor and not to stop taking it suddenly without medical advice.

Side Effects and Safety

Like all medications, carbamazepine can cause side effects. Common side effects may include:

  • Drowsiness
  • Dizziness
  • Nausea
  • Vomiting
  • Blurred vision
  • Headache

More serious side effects can include liver problems, blood disorders, and severe skin reactions. Your doctor will monitor you for these potential issues[3][2].

Drug Interactions

Carbamazepine can interact with many other medications. It’s known to be a strong inducer of an enzyme called CYP3A4, which is involved in processing many drugs in the body. This means it can affect how other medications work[5][6].

For example, carbamazepine can interact with:

  • Other antiepileptic drugs
  • Some antibiotics
  • Some antidepressants
  • Certain HIV medications

Always inform your doctor about all medications, supplements, and herbal products you’re taking to avoid potential interactions.

Ongoing Research

Research on carbamazepine is ongoing to explore its potential in treating other conditions and to better understand its effects:

  • It’s being studied for its potential in preventing chemotherapy-induced nausea and vomiting[4].
  • Researchers are investigating its use in treating severe liver disease due to alpha-1 antitrypsin deficiency[7].
  • Studies are being conducted to compare its effectiveness when used alone versus in combination with other medications like pregabalin for trigeminal neuralgia[2].

These ongoing studies may lead to new uses for carbamazepine or improvements in how it’s used in the future.

Condition Study Focus Key Findings/Objectives
Liver Disease (Alpha-1 Antitrypsin Deficiency) Efficacy and safety of carbamazepine in reducing hepatic ATZ accumulation Aims to reduce liver fibrosis, lower portal pressure, and stabilize disease severity
Bipolar Disorder in Children/Adolescents Dose tolerance and safety of extended-release carbamazepine Evaluates efficacy in treating acute manic or mixed episodes in 10-17 year olds
Trigeminal Neuralgia Comparison of carbamazepine with lamotrigine; Combination therapy with pregabalin Assesses pain relief, quality of life, and reduction in carbamazepine dosage
Diabetic Neuropathic Pain Efficacy and tolerability of carbamazepine in diabetic patients Measures pain reduction using Brief Pain Inventory scale and evaluates quality of life
Cocaine Dependence Carbamazepine as a potential treatment Assesses carbamazepine’s efficacy in managing cocaine dependence
Bronchial Asthma Carbamazepine’s effect on asthma symptoms and lung function Evaluates changes in Peak Expiratory Flow Rate and reduction in asthma symptoms

FAQ

  • What is carbamazepine primarily used for? Carbamazepine is primarily used as an anticonvulsant medication to treat epilepsy and neuropathic pain conditions. It is also used as a mood stabilizer in bipolar disorder.
  • What new conditions are being studied for carbamazepine treatment? Recent clinical trials are exploring carbamazepine's potential in treating conditions such as severe liver disease due to alpha-1 antitrypsin deficiency, trigeminal neuralgia, diabetic neuropathic pain, cocaine dependence, and even bronchial asthma.
  • How is carbamazepine being studied in liver disease? A clinical trial is investigating whether carbamazepine can reduce hepatic accumulation of ATZ (a mutant protein) in patients with severe liver disease due to alpha-1 antitrypsin deficiency, potentially reducing liver fibrosis and improving liver function.
  • What is being compared in the trigeminal neuralgia studies? In trigeminal neuralgia studies, researchers are comparing the efficacy and safety of carbamazepine to newer drugs like lamotrigine, as well as studying combination therapies such as carbamazepine with pregabalin to improve pain relief and reduce side effects.
  • Why is carbamazepine being studied for asthma treatment? Carbamazepine is being studied for asthma treatment based on the hypothesis that asthma, like other paroxysmal inflammatory diseases such as migraine, might respond to antiepileptic drugs. The study aims to evaluate if carbamazepine can improve lung function and reduce asthma symptoms.

Ongoing Clinical Trials on Carbamazepine

  • Study on the Effects of Sirolimus and Drug Combination for Children Under 4 Months with Tuberous Sclerosis Complex

    Recruiting

    1 1 1
    Investigated drugs:
    Austria Germany

  • Study of drug interactions between leriglitazone, gemfibrozil, itraconazole, and carbamazepine and food effects in healthy male volunteers for adrenoleukodystrophy treatment

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

Glossary

  • Carbamazepine: An anticonvulsant and mood-stabilizing drug used primarily to treat epilepsy and neuropathic pain. It works by decreasing nerve impulses that cause seizures and pain.
  • Alpha-1 Antitrypsin Deficiency: A genetic disorder that can cause lung and liver disease due to the lack of a protein called alpha-1 antitrypsin.
  • Trigeminal Neuralgia: A chronic pain condition affecting the trigeminal nerve in the face, characterized by sudden, severe facial pain.
  • Neuropathic Pain: Pain caused by damage or disease affecting the nervous system, often described as burning, stabbing, or shooting pain.
  • Bipolar Disorder: A mental health condition characterized by extreme mood swings including emotional highs (mania or hypomania) and lows (depression).
  • Bioequivalence: The property of two drug products having the same biological effect and availability in the body when administered at the same dose.
  • Peak Expiratory Flow Rate (PEFR): A measure of how quickly a person can exhale air from their lungs, used to assess lung function in conditions like asthma.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare with the effects of the active drug being tested.
  • Adverse Event: Any unfavorable and unintended sign, symptom, or disease temporarily associated with the use of a medical treatment or procedure.
  • Controlled Release (CR): A drug formulation designed to release the active ingredient slowly over time, maintaining a consistent level of the drug in the body.

References

  1. https://clinicaltrials.gov/study/NCT02132897
  2. https://clinicaltrials.gov/study/NCT06357260
  3. https://clinicaltrials.gov/study/NCT02623504
  4. https://clinicaltrials.gov/study/NCT01581918
  5. https://clinicaltrials.gov/study/NCT06646042
  6. https://clinicaltrials.gov/study/NCT04962230
  7. https://clinicaltrials.gov/study/NCT01379469